A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2011
11/15/2011	US8057797 Method of preparing enriched antibodies for detecting mycobacterial infection
11/15/2011	US8057796 Compositions and methods for the therapy and diagnosis of influenza
11/15/2011	US8057795 Using natural killer cell receptor modulators as therapeutic tools in prevention and treatment of viral diseases
11/15/2011	US8057794 Antibody molecules which bind to human IL-17
11/15/2011	US8057793 Anti-CD20 antibodies and fusion proteins thereof and methods of use
11/15/2011	US8057792 Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
11/15/2011	US8057791 Human antibodies specific to KDR and uses thereof
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2461989C Method for treating multiple myeloma
11/15/2011	CA2422635C In vitro assay for measuring the immunogenicity of a vaccine
11/15/2011	CA2421791C Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2392877C Improvements in or relating to immune responses to hiv
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/10/2011	WO2011140550A2 Immunogen adherence and method of making and using same
11/10/2011	WO2011140522A1 METHODS FOR THE TREATMENT OF IL-1β RELATED CONDITIONS
11/10/2011	WO2011140337A2 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	WO2011140295A2 Modulators of notch receptor signaling and methods of use thereof
11/10/2011	WO2011140284A2 Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
11/10/2011	WO2011140267A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011	WO2011140255A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	WO2011140254A1 Antibodies against epidermal growth factor receptor (egfr) and uses thereof
11/10/2011	WO2011140249A2 Antibodies that bind csf1r
11/10/2011	WO2011140135A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
11/10/2011	WO2011140132A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
11/10/2011	WO2011139988A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
11/10/2011	WO2011139986A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
11/10/2011	WO2011139985A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2011	WO2011139973A2 Methods of inhibiting fibrosis using anti-pai-1 antibodies
11/10/2011	WO2011139907A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
11/10/2011	WO2011139846A2 Compositions and methods for reduced scarring and for treatment of fibrosis
11/10/2011	WO2011139801A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
11/10/2011	WO2011139799A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
11/10/2011	WO2011139738A2 Therapies using zanolimumab to enhance the immune response
11/10/2011	WO2011139718A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations
11/10/2011	WO2011139714A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
11/10/2011	WO2011139391A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
11/10/2011	WO2011139385A2 Genetic signatures in hiv-1 subtype c envelope glycoproteins
11/10/2011	WO2011139375A1 Antibodies directed against carbonic anhydrase ix and methods and uses thereof
11/10/2011	WO2011139368A2 Methods of treatment of inflammatory diseases
11/10/2011	WO2011138586A1 Dengue virus vaccine
11/10/2011	WO2011138557A2 Use of an anti-cd71 antibody for preparing a medicament
11/10/2011	WO2011138513A1 Vaccine composition for preventing or treating leishmaniases
11/10/2011	WO2011138462A1 Diagnostic method for the detection of cells ex vivo
11/10/2011	WO2011138392A1 Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
11/10/2011	WO2011138391A1 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
11/10/2011	WO2011138361A1 Capsular gram-positive bacteria bioconjugate vaccines
11/10/2011	WO2011138354A1 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column
11/10/2011	WO2011138279A1 Novel antibody to a carbonic anhydrase
11/10/2011	WO2011138251A1 Lentiviral vector based immunological compounds against malaria
11/10/2011	WO2011138229A1 Novel method
11/10/2011	WO2011138050A1 Method for vaccination
11/10/2011	WO2011138032A2 Universal influenza vaccines and methods for their generation
11/10/2011	WO2011137687A1 Antibody against carcinoembryonic antigen and uses thereof
11/10/2011	WO2011137571A1 Human-derived neutralizing antibody rvfab5 against rabies virus glycoprotein
11/10/2011	WO2011137570A1 Human-derived neutralizing antibody rvfab8 against rabies virus glycoprotein
11/10/2011	WO2011137569A1 Humanized neutralizing antibody rvfab3 against rabies virus glycoprotein
11/10/2011	WO2011137540A1 Gfi1b modulation and uses thereof
11/10/2011	WO2011137491A1 Novel drug delivery system
11/10/2011	WO2011120013A9 Vista regulatory t cell mediator protein, vista binding agents and use thereof
11/10/2011	WO2011113819A3 Diagnosis and treatment of cancer based on avl9
11/10/2011	WO2011112945A3 Foot and mouth disease virus recombinant vaccines and uses thereof
11/10/2011	WO2011112599A3 Immunogenic pote peptides and methods of use
11/10/2011	WO2011094357A3 Repiratory virus epitopes templated into double stranded coiled -coils and use thereof in immunization
11/10/2011	WO2011090712A3 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
11/10/2011	WO2011087835A3 Novel compositions and methods for treating inflammatory bowel disease and airway inflammation
11/10/2011	WO2011084967A3 Methods and compositions for providing protective immunity in the elderly
11/10/2011	WO2011084604A3 Flavivirus species-specific peptide tags for vaccine and diagnostic use
11/10/2011	WO2011066390A3 Nanoscale adjuvants and related pharmaceutical compositions and methods
11/10/2011	WO2011066369A9 Antagonists of il-6 to raise albumin and/or lower crp
11/10/2011	WO2011050168A3 Rsv immunogens, antibodies and compositions thereof
11/10/2011	WO2010093706A3 Chemically programmed vaccination
11/10/2011	US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids
11/10/2011	US20110274757 Nucleic acid delivery vehicle and uses thereof
11/10/2011	US20110274748 CAI-Based Systems and Methods for the Localized Treatment of Ocular and Other Diseases
11/10/2011	US20110274739 Methods for governing tissue growth
11/10/2011	US20110274738 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274723 Cancer immunotherapy and method of treatment
11/10/2011	US20110274722 Food containing a probiotic and an isolated beta-glucan and methods of use thereof
11/10/2011	US20110274721 Hiv vaccines based on env of multiple clades of hiv
11/10/2011	US20110274720 Capsular gram-positive bacteria bioconjugate vaccines
11/10/2011	US20110274719 Helicobacter system and uses thereof
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274717 POLYSACCHARIDE CONJUGATION WITH DETOXIFIED E. coli HEAT LABILE ENTEROTOXIN (LT) USED AS VACCINE
11/10/2011	US20110274714 Broad Spectrum Vaccine Against Non-Typhoidal Salmonella
11/10/2011	US20110274713 Antigen-presenting scaffolds
11/10/2011	US20110274712 Antigenic compositions
11/10/2011	US20110274710 Pcv2 immunogenic compositions and methods of producing such compositions
11/10/2011	US20110274709 T-Cell Immunogens Derived from Anti-Viral Proteins and Methods of Using Same
11/10/2011	US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011	US20110274707 Composition for improving inflammatory disease using abh antigens
11/10/2011	US20110274705 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274703 Detection and treatment of non-dermal fibrosis
11/10/2011	US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof
11/10/2011	US20110274701 Composition and method for preventing/decreasing respiratory illness

1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 1823